Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pharma Ophthalmic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pharma Ophthalmicmarket, defines the market attractiveness level of Pharma Ophthalmic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pharma Ophthalmic industry, describes the types of Pharma Ophthalmic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharma Ophthalmic market and the development prospects and opportunities of Pharma Ophthalmic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharma Ophthalmic market in Chapter 13.
By Player:
Roche
Pfizer
Bayer
Novartis
Regeneron
Akorn
Allergan
Valeant
Senju
Santen
By Type:
Retinal Disorders Drugs
Allergic, Inflammatory and Infective Drugs
Glaucoma Drugs
Dry Eye Drugs
Other Ophthalmic Drugs
By End-User:
Glaucoma
Dry Eye Syndrome
Retinal Diseases
Other Ophthalmic Indications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pharma Ophthalmic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pharma Ophthalmic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pharma Ophthalmic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pharma Ophthalmic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pharma Ophthalmic Market Analysis and Outlook to 2022
-
7.1 Global Pharma Ophthalmic Consumption (2017-2022)
-
7.2 United States Pharma Ophthalmic Consumption (2017-2022)
-
7.3 Europe Pharma Ophthalmic Consumption (2017-2022)
-
7.4 China Pharma Ophthalmic Consumption (2017-2022)
-
7.5 Japan Pharma Ophthalmic Consumption (2017-2022)
-
7.6 India Pharma Ophthalmic Consumption (2017-2022)
-
7.7 South Korea Pharma Ophthalmic Consumption (2017-2022)
8 Region and Country-wise Pharma Ophthalmic Market Analysis and Outlook to 2028
-
8.1 Global Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.2 United States Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.3 Europe Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.4 China Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.5 Japan Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.6 India Pharma Ophthalmic Consumption Forecast (2022-2028)
-
8.7 South Korea Pharma Ophthalmic Consumption Forecast (2022-2028)
9 Global Pharma Ophthalmic Market Outlook by Types and Applications to 2022
-
9.1 Global Pharma Ophthalmic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Allergic, Inflammatory and Infective Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glaucoma Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Dry Eye Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharma Ophthalmic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Glaucoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retinal Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Ophthalmic Indications Consumption and Growth Rate (2017-2022)
10 Global Pharma Ophthalmic Market Outlook by Types and Applications to 2028
-
10.1 Global Pharma Ophthalmic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Allergic, Inflammatory and Infective Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glaucoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Dry Eye Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pharma Ophthalmic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Ophthalmic Indications Consumption Forecast and Growth Rate (2022-2028)
11 Global Pharma Ophthalmic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pharma Ophthalmic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pharma Ophthalmic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pharma Ophthalmic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pharma Ophthalmic Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Pharma Ophthalmic Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Pharma Ophthalmic Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Pharma Ophthalmic Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Pharma Ophthalmic Product and Service
-
14.5 Regeneron
-
14.5.1 Regeneron Company Details
-
14.5.2 Regeneron Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Regeneron Pharma Ophthalmic Product and Service
-
14.6 Akorn
-
14.6.1 Akorn Company Details
-
14.6.2 Akorn Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Akorn Pharma Ophthalmic Product and Service
-
14.7 Allergan
-
14.7.1 Allergan Company Details
-
14.7.2 Allergan Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Allergan Pharma Ophthalmic Product and Service
-
14.8 Valeant
-
14.8.1 Valeant Company Details
-
14.8.2 Valeant Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Valeant Pharma Ophthalmic Product and Service
-
14.9 Senju
-
14.9.1 Senju Company Details
-
14.9.2 Senju Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Senju Pharma Ophthalmic Product and Service
-
14.10 Santen
-
14.10.1 Santen Company Details
-
14.10.2 Santen Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Santen Pharma Ophthalmic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pharma Ophthalmic
-
Figure Pharma Ophthalmic Picture
-
Table Global Pharma Ophthalmic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharma Ophthalmic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharma Ophthalmic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pharma Ophthalmic Consumption by Country (2017-2022)
-
Figure United States Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Table Europe Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure China Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure India Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharma Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure Global Pharma Ophthalmic Consumption Forecast by Country (2022-2028)
-
Figure United States Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharma Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Allergic, Inflammatory and Infective Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Glaucoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Eye Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Ophthalmic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Glaucoma Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Eye Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Ophthalmic Indications Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergic, Inflammatory and Infective Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glaucoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry Eye Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Ophthalmic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry Eye Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Ophthalmic Indications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pharma Ophthalmic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pharma Ophthalmic Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Pharma Ophthalmic Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pharma Ophthalmic Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Pharma Ophthalmic Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharma Ophthalmic Product and Service
-
Table Regeneron (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharma Ophthalmic Product and Service
-
Table Akorn (Foundation Year, Company Profile and etc.)
-
Table Akorn Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Pharma Ophthalmic Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Pharma Ophthalmic Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharma Ophthalmic Product and Service
-
Table Senju (Foundation Year, Company Profile and etc.)
-
Table Senju Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senju Pharma Ophthalmic Product and Service
-
Table Santen (Foundation Year, Company Profile and etc.)
-
Table Santen Pharma Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Santen Pharma Ophthalmic Product and Service
-
